AngioDynamics To Present At RBC Capital Markets Healthcare Conference

ALBANY, N.Y., Feb. 13, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Tuesday, February 26, 2013 at 8 a.m. Eastern Time in New York City. Joseph DeVivo, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments.

A live webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com .

Trademarks

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:         AngioDynamics, Inc.         Mark Frost, CFO         (800) 772-6446 x1981         mfrost@AngioDynamics.com                  Investor Relations Contacts:         EVC Group, Inc.         Greg Gin/Robert Jones         (646) 445-4801; (646) 201-5447         ggin@evcgroup.com; bjones@evcgroup.com                  Media Contact:         EVC Group, Inc.         Chris Gale         (646) 201-5431         cgale@evcgroup.com

If you liked this article you might like

Endo international, AngioDynamics Lead Biotech Movers

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

5 Stocks Everyone Hates -- but You Should Love

AngioDynamics (ANGO) Strong On High Relative Volume Today

5 Hated Earnings Stocks You Should Love